Skip to ContentGo to accessibility page
OpenStax Logo
Pharmacology for Nurses

Chapter 21

Pharmacology for NursesChapter 21

Chapter 21

Review Questions

1.
b. Medications can be used to decrease cholesterol levels but are not intended to increase triglyceride levels.
2.
b. Alirocumab is a monoclonal antibody that is self-administered by the client.
3.
d. Fenofibrate is indicated to treat hypertriglyceridemia. Fibrates stimulate lipoprotein lipase to break down triglycerides.
4.
c. Flushing can be mitigated by taking an NSAID 30 minutes before taking niacin or by switching to an extended-release product.
5.
b. The therapeutic effect of ezetimibe is that of lowering LDL-cholesterol via decreased cholesterol absorption.
6.
c. Cholestyramine is a bile acid sequestrant available as a powder. It must be mixed with fluid prior to administration.
7.
c. Rosuvastatin at a dose of 20–40 mg daily is considered a high-intensity statin medication.
8.
a. Pravastatin is considered a hydrophilic statin. It can less easily enter the muscle, which may confer a lower risk of myalgia.
9.
d. Ezetimibe is an appropriate combination therapy with statin medications. Gemfibrozil is contraindicated for use with rosuvastatin. Rosuvastatin does not need to be taken at bedtime because it has a long half-life.
10.
a. This drug may cause severe myopathy, which can lead to rhabdomyolysis.
PreviousNext
Order a print copy
Citation/Attribution
Reuse and redistribution of this content in digital or print format:
  • This book may not be used in the training of large language models or otherwise be ingested into large language models or generative AI offerings without OpenStax's prior written permission.
  • This book uses the Creative Commons Attribution-NonCommercial-ShareAlike License, which means that you can reuse and modify the material only for noncommercial purposes, must attribute OpenStax, and must distribute any derivative works under the same license.
  • Any commercial printing of this textbook, including using a local or custom printer, must be approved by OpenStax, and proper citation provided.
  • OpenStax-copyrighted images, activities, assessments, and similar components of this book are subject to the same licensing – CC-BY-NC-SA. They can be used for noncommercial purposes with attribution. Commercial use requires permission.
  • Permission requests: Anyone who intends to incorporate this content (including text, images, and other components) into large language models, use it in AI offerings, use it commercially (including in print), and/or has questions about another use case is welcome to complete our reuse request form.
Attribution information
  • If you are redistributing all or part of this book in a noncommercial print format, then you must include on every physical page the following attribution:

    Access for free at https://openstax.org/books/pharmacology/pages/1-introduction

  • If you are redistributing all or part of this book in a noncommercial digital format, then for every page that includes OpenStax content, you must license the derivative work under the same CC-BY-NC-SA license as the original, and include on every digital page view the following attribution:

    Access for free at https://openstax.org/books/pharmacology/pages/1-introduction

Citation information

The information below includes the information needed to generate citations in most major styles (APA, MLA, etc.); you must reformat and organize the information as needed to fit the requirements of the style. Use the information below to generate a citation. We recommend using a citation tool such as this one.

© Apr 23, 2026 OpenStax. Textbook content produced by OpenStax is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike License. The OpenStax name, OpenStax logo, OpenStax book covers, OpenStax CNX name, and OpenStax CNX logo, and Rice University name, and Rice University logo trademarks, or wordmarks are not subject to the Creative Commons license and may not be reproduced without the prior and express written consent of Rice University.